Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Piramal Pharma Limited, is an unlisted public company incorporated on 04 March, 2020. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 3,000.00 cr and the total paid-up capital is INR 1,329.25 cr.
Piramal Pharma Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2024. It's EBITDA has increased by 533.57% over the previous year. At the same time, it's book networth has increased by 27.56%.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Whole-time Director | Peter D Deyoung
Shareholder
|
07152550 | 5 years |
Director | Ramadorai Subramanian
Shareholder
|
00000002 | 5 years |
Director | Jairaj Manohar Purandare | 00159886 | 5 years |
Director | Sridhar Gorthi | 00035824 | 3 years |
Whole-time Director | Nandini Ajay Piramal
Shareholder
|
00286092 | 5 years |
Whole-time Director | Vivek Valsaraj
Shareholder
|
06970246 | 4 years |
Director | Peter Andrew Stevenson | 09544706 | 3 years |
Director | Nathalie Ann Leitch | 09557042 | 1 years |
Director | Vibha Paul Rishi | 05180796 | 3 years |
Additional Director | Amit Jain | 06917608 | 0 years |
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | ||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO |
IDBI Trusteeship Services Limited
No. of Loans: 9
Total Amount : 1,580.0 cr
The Hongkong and Shanghai Banking Corporation Limited
No. of Loans: 2
Total Amount : 300.0 cr
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 200.0 cr
IndusInd Bank Limited
No. of Loans: 1
Total Amount : 200.0 cr
BNP Paribas
No. of Loans: 1
Total Amount : 50.0 cr
CitiBank N.A.
No. of Loans: 1
Total Amount : 50.0 cr
Standard Chartered Bank
No. of Loans: 1
Total Amount : 50.0 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Piramal Critical Care Deutschland GmbH | Germany | - | - |
Piramal Critical Care Italia, S.P.A | Italy | - | - |
Piramal Critical Care Limited | United Kingdom | - | - |
Piramal Healthcare (Canada) Limited | Canada | - | - |
Piramal Healthcare (UK) Limited | United Kingdom | - | - |
Piramal Healtchare Pension Trustees Limited | United Kingdom | - | - |
Piramal Critical Care South Africa (Pty) Ltd | South Africa | - | - |
Piramal Dutch Holdings N.V. | Netherlands | - | - |
Piramal Healthcare Inc. | United States | - | - |
Piramal Critical Care, Inc. | United States | - | - |
Piramal Pharma Inc. | United States | - | - |
Piramal Pharma Solutions Inc. | United States | - | - |
PEL Pharma Inc. | United States | - | - |
Ash Stevens LLC | United States | - | - |
Piramal Critical Care B.V. | Netherlands | - | - |
Piramal Critical Care Pty Limited | Australia | - | - |
PEL Healthcare LLC | United States | - | - |
Piramal Pharma Solutions (Dutch) B.V. | Netherlands | - | - |
PCC Greece | Greece | - | - |
PIRAMAL PHARMA II PRIVATE LIMITED | Maharashtra | 2022 | ₹ 34.0 Cr |
Pharma Limited Employees Welfare Trust | India | - | - |
Read more
The incorporation date of PIRAMAL PHARMA LIMITED is 04 March, 2020
The authorized share capital of PIRAMAL PHARMA LIMITED is INR ₹ 3,000.0 Cr.
The paid-up capital of PIRAMAL PHARMA LIMITED is INR ₹ 1,329.2 Cr.
The registered address of PIRAMAL PHARMA LIMITED is Gr. Flr., Piramal Ananta, Agastya Corp. Park, Kamani Junction, LBS Marg, Kurla, Mumbai City, MUMBAI, Maharashtra, India, 400070 - 400070
The CIN number of PIRAMAL PHARMA LIMITED is L24297MH2020PLC338592.